SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,955.00    505.00 (11.35%)
Bid:
4,900.00
Ask:
5,010.00
Spread: 110.00 (2.245%)
Market Cap: £330.04m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Acquisition

21 Mar 2011 07:00

RNS Number : 2707D
Judges Scientific PLC
21 March 2011
Β 

JUDGES SCIENTIFIC plc

("Judges Scientific", "Judges" or the "Company")

Β 

ACQUISITION OF 51% OF DEBEN UK LIMITED

Β 

Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, announces that it completed on 18 March the acquisition of a 51% indirect interest in Deben UK Limited ("Deben") for a cash consideration of Β£3.26 million (the "Acquisition").

Β 

An additional payment will be made to reflect the working capital available at completion in excess of the ongoing requirements of the business. Such payment is expected by Judges to be covered by the cash inherited on completion.

Β 

The Acquisition has been executed through Bordeaux Acquisition Limited ("BAL"), a 51% owned subsidiary of Judges, which was created for the purpose of effecting the acquisition and which acquired the entirety of Deben's share capital.

Β 

Financing of the Acquisition

The Acquisition and associated transaction costs are being financed through a Β£2,422,250 loan provided by Lloyds Bank Corporate Markets to BAL. The loan is split into two parts, both guaranteed by Judges, and comprises an acquisition component of Β£2.06 million and a property element of Β£362,250, secured against the freehold property from which Deben operates its business.

Β 

Equity of Β£1,013,250 was supplied by the BAL shareholders, pro-rata to their respective interests, predominantly in the form of subordinated loans. Gary and Tracey Edwards, the vendors of Deben, have reinvested Β£497,000 of their sale proceeds to acquire a 49% shareholding in BAL, while Judges invested Β£516,250 in respect of its 51% interest.

Β 

Both parties have entered into a Shareholders' Agreement which includes minority protection provisions and stipulates, inter alia, that BAL has the right of first refusal on potential acquisitions available to the Judges group, provided that such acquisitions meet certain criteria, operate in the field of electron microscopy and can be financed independently by BAL.

Β 

Information on Deben

Deben designs, manufactures and sells devices used to enable or improve the observation of objects under a microscope. The principal product groups are motor control systems, micro-tensile stages, cooling stages, digital imaging for electron microscopes and beam blanking equipment. The products are sold world-wide to OEM customers (microscope manufacturers that incorporate such equipment in their own instruments) or directly to end users such as universities.

Β 

The business, established in 1987, is based in Woolpit, Suffolk, and has been managed by Gary Edwards since 1996. It is expected that Mr Edwards, 44, will continue as managing director of Deben for the foreseeable future.

Β 

Deben's unaudited accounts for the year ended 31 October 2010 show sales of Β£2 million and pre-tax profits of Β£862,000. Operating profits, adjusted to eliminate non-recurring items and to reflect Judges Scientific's practices, would have amounted to Β£707,000. The accounts show net tangible assets of Β£2.25 million including net cash of Β£1.36 million. The freehold property was valued on BAL's behalf at Β£517,500. The price paid for Deben reflects this valuation as well as a multiple of adjusted operating profit.

Β 

The Board believes that this acquisition is an excellent addition to the Group's electron microscopy business and will be immediately earnings enhancing.

Β 

Alex Hambro, Chairman of Judges, commented:

"We are delighted to be able to expand our electron microscopy business through the acquisition of Deben. This is a profitable and cash generative business and we expect the transaction, which has not involved the issue of new equity, to be immediately earnings enhancing. We welcome Gary and his team into the Judges group for what we anticipate will be a long and fruitful relationship ".

Β 

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

Β 

Pascal Keane, Shore Capital: Tel: 020 7408 4090

Β 

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

Β 

Websites:

Β Judges Scientific:www.judges.uk.com

Β 

Deben: www.deben.co.uk

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQURSSRAKAOUAR
Date   Source Headline
30th Mar 20123:49 pmRNSDirector/PDMR Shareholding and Exercise of Options
29th Mar 20127:00 amRNSFinal Results
12th Mar 20126:17 pmRNSHolding(s) in Company
7th Mar 20127:00 amRNSACQUISITION OF GLOBAL DIGITAL SYSTEMS LIMITED
22nd Feb 201210:00 amRNSAcquisition of KE Developments Limited
19th Jan 20127:00 amRNSTrading Statement
16th Nov 20117:00 amRNSTrading Statement
6th Oct 201111:59 amRNSDirector/PDMR Shareholding and Exercise of Options
28th Sep 20117:00 amRNSHalf Yearly Report
14th Sep 20117:00 amRNSNotice of Results
22nd Jul 20115:04 pmRNSDirector/PDMR Shareholding
18th Jul 20117:00 amRNSTrading Statement
27th May 20117:00 amRNSIssue of Equity
26th May 20114:28 pmRNSDirector/PDMR Shareholding
10th May 20117:00 amRNSDirector/PDMR Shareholding
28th Apr 20119:25 amRNSHolding(s) in Company
15th Apr 20115:03 pmRNSDirector/PDMR Shareholding
7th Apr 20112:48 pmRNSHolding(s) in Company
5th Apr 20116:05 pmRNSDirector/PDMR Shareholding
5th Apr 20115:44 pmRNSDirector/PDMR Shareholding
4th Apr 20116:28 pmRNSDirector/PDMR Shareholding
1st Apr 201110:51 amRNSHolding(s) in Company
30th Mar 20117:00 amRNSFinal Results
21st Mar 20117:00 amRNSAcquisition
4th Mar 20117:00 amRNSNotice of Results
20th Jan 20117:00 amRNSTrading Statement
13th Jan 201111:10 amRNSDirector/PDMR Shareholding
22nd Nov 20105:20 pmRNSExercise of options
17th Nov 20107:00 amRNSTrading Statement
11th Oct 20106:17 pmRNSHolding(s) in Company
28th Sep 20107:00 amRNSExercise of Options
22nd Sep 20107:00 amRNSHalf Yearly Report
9th Sep 20102:00 pmRNSNotice of Results
21st Jul 201012:08 pmRNSHolding(s) in Company
20th Jul 201012:04 pmRNSHolding(s) in Company
20th Jul 20109:13 amRNSDirector/PDMR Shareholding
16th Jul 20107:00 amRNSTrading Statement
25th May 201012:17 pmRNSResult of AGM
21st May 20109:35 amRNSIssue of Equity
26th Mar 20107:00 amRNSFinal Results
19th Mar 20107:00 amRNSAcquisition
4th Mar 20105:25 pmRNSNotice of Results
22nd Jan 201011:15 amRNSShare buyback programme
22nd Jan 20107:00 amRNSTrading Statement
14th Jan 201010:20 amRNSHolding(s) in Company
11th Dec 20097:00 amRNSTrading Statement
20th Oct 200910:55 amRNSExercise of options
2nd Oct 20097:00 amRNSDirector/PDMR Shareholding
29th Sep 20097:00 amRNSHalf Yearly Report
22nd Sep 20097:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.